rs973057702

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PM4_SupportingBP6

The NM_001378454.1(ALMS1):​c.90_92delAGC​(p.Ala31del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000439 in 1,367,512 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A30A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

ALMS1
NM_001378454.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.806

Publications

0 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_001378454.1. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 2-73385955-TGCA-T is Benign according to our data. Variant chr2-73385955-TGCA-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 550960.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.90_92delAGC p.Ala31del disruptive_inframe_deletion Exon 1 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.90_92delAGC p.Ala31del disruptive_inframe_deletion Exon 1 of 23 NP_055935.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.90_92delAGC p.Ala31del disruptive_inframe_deletion Exon 1 of 23 1 NM_001378454.1 ENSP00000482968.1

Frequencies

GnomAD3 genomes
AF:
0.00000674
AC:
1
AN:
148308
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000210
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000410
AC:
5
AN:
1219080
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
608932
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28302
American (AMR)
AF:
0.00
AC:
0
AN:
34680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23512
East Asian (EAS)
AF:
0.000119
AC:
4
AN:
33728
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73752
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5092
European-Non Finnish (NFE)
AF:
0.00000109
AC:
1
AN:
919622
Other (OTH)
AF:
0.00
AC:
0
AN:
51888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.565
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000674
AC:
1
AN:
148432
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
1
AN XY:
72314
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40852
American (AMR)
AF:
0.00
AC:
0
AN:
14940
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3418
East Asian (EAS)
AF:
0.000210
AC:
1
AN:
4756
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4574
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66612
Other (OTH)
AF:
0.00
AC:
0
AN:
2036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alstrom syndrome Uncertain:2
Dec 23, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.93_95del, results in the deletion of 1 amino acid(s) of the ALMS1 protein (p.Ala36del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 550960). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Mar 02, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Cardiovascular phenotype Benign:1
Jan 14, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.81
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs973057702; hg19: chr2-73613083; API